Metoclopramide 5 mg/mL (Metoclopramide Hydrochloride INJECTION) 5 mg/mL

Metoclopramide 5 mg/mL is an injectable medication used for nausea, vomiting, and gastrointestinal motility issues. This prescription drug is available in 10 mL vials, suitable for intramuscular or intravenous administration.

Strength

5 mg/mL

Pack Size

25 VIAL in 1 CARTON (23155-240-42) / 10 mL in 1 VIAL (23155-240-32)

Manufacturer / TM Owner

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metoclopramide is commonly used to manage nausea and vomiting, including postoperative and chemotherapy-induced cases. It may also help with gastrointestinal motility disorders, such as gastroparesis, by enhancing stomach emptying. This medication is often prescribed when oral administration is not feasible or effective.

Side Effects

Metoclopramide may cause drowsiness, dizziness, or diarrhea. Some users report restlessness or headache. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Metoclopramide should be used with caution in patients with a history of seizures, Parkinson's disease, or kidney issues. It is important to follow the prescribed dosage and administration route. Avoid sudden discontinuation without medical guidance.

Avoid Interactions

Metoclopramide may interact with alcohol, sedatives, and certain antidepressants. It can also affect the metabolism of drugs processed by liver enzymes. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Metoclopramide is used to treat nausea, vomiting, and gastrointestinal motility disorders, such as gastroparesis.

Metoclopramide 5 mg/mL is administered via intramuscular or intravenous injection, as prescribed by a healthcare provider.

Common side effects may include drowsiness, dizziness, diarrhea, restlessness, or headache.

Metoclopramide may interact with alcohol, sedatives, and certain antidepressants. Consult a healthcare provider before combining medications.

Patients with a history of seizures, Parkinson's disease, or kidney issues should use Metoclopramide with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.